210 related articles for article (PubMed ID: 9723818)
21. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
22. Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women.
Baumann A; Fuhrmeister A; Brudny-Klöppel M; Draeger C; Bunte T; Kuhnz W
Contraception; 1996 Oct; 54(4):235-42. PubMed ID: 8922877
[TBL] [Abstract][Full Text] [Related]
23. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
Letterie GS
Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
[TBL] [Abstract][Full Text] [Related]
24. Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?
Balogh A; Gessinger S; Svarovsky U; Hippius M; Mellinger U; Klinger G; Hoffmann A; Oettel M
Eur J Clin Pharmacol; 1998; 54(9-10):729-34. PubMed ID: 9923576
[TBL] [Abstract][Full Text] [Related]
25. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
26. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
27. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
[TBL] [Abstract][Full Text] [Related]
28. The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel.
Olsson B; Landgren BM
Clin Ther; 2001 Nov; 23(11):1876-88. PubMed ID: 11768839
[TBL] [Abstract][Full Text] [Related]
29. [Clinical pharmacokinetic study of Org5187 as a low-dose oral contraceptive].
Mizuno M; Kuwabara Y; Taketani Y; Yazima A; Hoshiai H; Fukaya T; Ishikawa M; Kobayashi T; Iizuka R; Tanabe K
Nihon Funin Gakkai Zasshi; 1991 Jan; 36(1):35-48. PubMed ID: 12158571
[TBL] [Abstract][Full Text] [Related]
30. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
31. Effect of contraceptive steroids on serum levels of sex hormone binding globulin and caeruloplasmin.
Limpongsanurak S; Jenkins N; Fotherby K
Curr Med Res Opin; 1981; 7(3):185-91. PubMed ID: 7194172
[TBL] [Abstract][Full Text] [Related]
32. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
[TBL] [Abstract][Full Text] [Related]
34. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
35. Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.
Trezza C; Ford SL; Gould E; Lou Y; Huang C; Ritter JM; Buchanan AM; Spreen W; Patel P
Br J Clin Pharmacol; 2017 Jul; 83(7):1499-1505. PubMed ID: 28087972
[TBL] [Abstract][Full Text] [Related]
36. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects.
Doose DR; Wang SS; Padmanabhan M; Schwabe S; Jacobs D; Bialer M
Epilepsia; 2003 Apr; 44(4):540-9. PubMed ID: 12681003
[TBL] [Abstract][Full Text] [Related]
37. Absence of an effect of high vitamin C dosage on the systemic availability of ethinyl estradiol in women using a combination oral contraceptive.
Zamah NM; Hümpel M; Kuhnz W; Louton T; Rafferty J; Back DJ
Contraception; 1993 Oct; 48(4):377-91. PubMed ID: 8222665
[TBL] [Abstract][Full Text] [Related]
38. Hormonal treatment for bleeding irregularities in Norplant implant users.
Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
[TBL] [Abstract][Full Text] [Related]
39. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
Moutos D; Smith S; Zacur H
Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
[TBL] [Abstract][Full Text] [Related]
40. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
Jung-Hoffmann C; Fitzner M; Kuhl H
Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
